Motesanib
TB-AB030103
Phase 3 small_molecule terminated
Quick answer
Motesanib for Carcinoma, Non-Small-Cell Lung is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Carcinoma, Non-Small-Cell Lung
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated